Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

Peter StarzengrÃ¼ber; Kamala Ley-Thriemer; Rashidul Haque; Wasifali Khan; Hans Fuehrer; Anja Siedl; Verena Hofecker; Benedikt Ley; Walther Wernsdorfer; Harald Noedl

doi:10.1128/AAC.00312-09

Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

Peter StarzengrÃ¼ber, Kamala Ley-Thriemer, Rashidul Haque, Wasifali Khan, Hans Fuehrer, Anja Siedl, Verena Hofecker, Benedikt Ley, Walther Wernsdorfer, Harald Noedl

Global and Tropical Health

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidence
interval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.

Original language	English
Pages (from-to)	4040-4042
Number of pages	3
Journal	Antimicrobial Agents and Chemotherapy
Volume	53
Issue number	9
DOIs	https://doi.org/10.1128/AAC.00312-09
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1128/AAC.00312-09

Cite this

@article{3a1684ff1d554ba3b46244e00ed70778,

title = "Antimalarial activity of tigecycline, a novel glycylcycline antibiotic",

abstract = "Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidenceinterval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.",

author = "Peter Starzengr{\~A}¼ber and Kamala Ley-Thriemer and Rashidul Haque and Wasifali Khan and Hans Fuehrer and Anja Siedl and Verena Hofecker and Benedikt Ley and Walther Wernsdorfer and Harald Noedl",

year = "2009",

doi = "10.1128/AAC.00312-09",

language = "English",

volume = "53",

pages = "4040--4042",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "9",

}

TY - JOUR

T1 - Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

AU - StarzengrÃ¼ber, Peter

AU - Ley-Thriemer, Kamala

AU - Haque, Rashidul

AU - Khan, Wasifali

AU - Fuehrer, Hans

AU - Siedl, Anja

AU - Hofecker, Verena

AU - Ley, Benedikt

AU - Wernsdorfer, Walther

AU - Noedl, Harald

PY - 2009

Y1 - 2009

N2 - Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidenceinterval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.

AB - Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidenceinterval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.

UR - http://www.scopus.com/inward/record.url?scp=70349130353&partnerID=8YFLogxK

U2 - 10.1128/AAC.00312-09

DO - 10.1128/AAC.00312-09

M3 - Article

SN - 0066-4804

VL - 53

SP - 4040

EP - 4042

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 9

ER -

Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this